| # | Drug | Count |
|---|---|---|
| 0 | SORAFENIB | 5 |
| 1 | ATEZOLIZUMAB | 3 |
| 2 | PREDNISOLONE | 3 |
| 3 | PREDNISOLONE ORAL | 3 |
| 4 | PREDNISOLONE ORAL SOLUTION | 3 |
| 5 | RITUXIMAB | 3 |
| 6 | AMLODIPINE | 2 |
| 7 | ASPIRIN | 2 |
| 8 | ASPIRIN 325 MG | 2 |
| 9 | ASPIRIN 81 MG | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYALURONATE SODIUM | 1 | 0.0007 |
| 1 | BEVACIZUMAB-AWWB | 2 | 0.0004 |
| 2 | AMIFAMPRIDINE PHOSPHATE | 1 | 0.0003 |
| 3 | BARICITINIB | 1 | 0.0003 |
| 4 | SORAFENIB | 5 | 0.0002 |
| 5 | VANCOMYCIN HYDROCHLORIDE | 2 | 0.0002 |
| 6 | ERLOTINIB HYDROCHLORIDE | 2 | 0.0002 |
| 7 | RAMUCIRUMAB | 1 | 0.0002 |
| 8 | APREPITANT | 1 | 0.0001 |
| 9 | ATOVAQUONE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 2 | Antimalarial [EPC] | 1 | 0.0001 |
| 3 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 4 | Vitamin D3 Analog [EPC] | 1 | 0.0000 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 4 | 0.0000 |
| 6 | Phenothiazine [EPC] | 1 | 0.0000 |
| 7 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Glycopeptide Antibacterial [EPC] | 2 | 0.0000 |
| 9 | Dietary Cholesterol Absorption Inhibitor [EPC] | 2 | 0.0000 |